They have revealed the hitherto unknown role of the NADPH oxidase NOX2 in immune recognition, thus shedding light on how the immune system works and so enhancing our capacity to manipulate and use it therapeutically. This discovery, published in the July 14, 2006 issue of Cell, should help us to fine-tune the immune response in the treatment of certain diseases like cancer.
The body is constantly under attack from outside forces (viruses and bacteria) and sometimes from forces within (cellular abnormalities leading to cancer). Its defensive response is to activate the immune system. There are two types of defense. First, there is innate immunity, which has no memory and so is constantly on the lookout for infectious agents to destroy. Second, there is adaptive immunity, which over time acquires memories of particular pathogens.
This requires a “learning” phase in which the dendritic cells degrade pathogenic agents into characteristic fragments, the epitopes, and then present these epitopes to the T and B lymphocytes, thereby initiating immune responses. The pathogen’s profile is memorized through this learning process and the next time the same pathogen is encountered the body immediately recognizes it and so is able to respond rapidly.
NOX2, immunity’s double agent
In innate immune responses, the invader is totally destroyed, a process in which the NADPH oxidase NOX2 plays a central role. In neutrophils, the cells at the heart of innate immune responses, NOX2 ensures the complete destruction of invading pathogens so they are no longer harmful to the body.
In adaptive immune responses, the dendritic cells’ challenge is to degrade the pathogen just partially, thus preserving sufficiently representative fragments that can be presented to the T and B lymphocytes. Ariel Savina at the Institut Curie, in the Inserm team of Sebastian Amigorena(1), has been studying how dendritic cells, the body’s “watchdogs”, achieve this controlled degradation of pathogens into epitopes. What they have found is that NOX2 is also implicated in adaptive immune responses. Its role in this case contrasts with that in neutrophils. NOX2 regulates the pH in the compartments (phagosomes) of the dendritic cells where pathogens are degraded, thus ensuring suitable acidity.
This pH regulation slows the degradation of the pathogens thus avoiding their complete destruction, which allows the dendritic cells to trigger a specific and efficient adaptive immune response.
These new findings shed light on how the immune system works and should help us to optimize one of the most promising approaches to cancer treatment: immunotherapy, in which the immune system is used to destroy tumor cells. The Institut Curie has for many years been participating actively in the development of innovative immunotherapeutic strategies. Two clinical trials are currently under way at the Institut Curie, one in patients with choroidal melanoma and another in cervical cancer patients. The results are expected some time in 2007.
(1) Sebastian Amigorena is CNRS Director of Research and Head of Inserm/Institut Curie Unit 653 “Immunity and cancer”.
Catherine Goupillon | alfa
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Health and Medicine
20.04.2018 | Materials Sciences
20.04.2018 | Earth Sciences